Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 10999 results:
[ Συντάκτης(Asc)] Τίτλος Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Z
Zarogoulidis, P., Huang H., Tsiouda T., Sardeli C., Trakada G., Veletza L., et al. (2017).  Immunotherapy "Shock" with vitiligo due to nivolumab administration as third line therapy in lung adenocarcinoma.. Respir Med Case Rep. 22, 283-286.
Zarogoulidis, P., Alexandropoulou I., Romanidou G., Konstasntinidis T. G., Terzi E., Saridou S., et al. (2011).  Community-acquired pneumonia due to Legionella pneumophila, the utility of PCR, and a review of the antibiotics used.. Int J Gen Med. 4, 15-9.
Zarogoulidis, P., Kioumis I., Tsiouda T., Pezirkianidis N., Ritzoulis C., Huang H., et al. (2014).  A 3D Polymer Model for Future Nutrition Design Novel Nutrition Approach for Cystic Fibrosis, Ulcerative Colitis and Crohn's Disease.. J Nanomedine Biotherapeutic Discov. 4(2), 128.
Zarogoulidis, K., Zarogoulidis P., Darwiche K., Boutsikou E., Machairiotis N., Tsakiridis K., et al. (2013).  Treatment of non-small cell lung cancer (NSCLC).. J Thorac Dis. 5 Suppl 4, S389-96.
Zarogoulidis, P., Chatzaki E., Hohenforst-Schmidt W., Goldberg E. P., Galaktidou G., Kontakiotis T., et al. (2012).  Management of malignant pleural effusion by suicide gene therapy in advanced stage lung cancer: a case series and literature review.. Cancer Gene Ther. 19(9), 593-600.
Zarogoulidis, P., Yarmus L., & Zarogoulidis K. (2013).  New insights for IL-6 targeted therapy as an adjuvant treatment for non-small-cell lung cancer.. Ther Deliv. 4(10), 1221-3.
Zarogoulidis, P., Chinelis P., Athanasiadou A., Tsiouda T., Trakada G., Kallianos A., et al. (2017).  Possible adverse effects of immunotherapy in non-small cell lung cancer; treatment and follow-up of three cases.. Respir Med Case Rep. 22, 101-105.
Zarogoulidis, K., Boutsikou E., Zarogoulidis P., Darwiche K., Freitag L., Porpodis K., et al. (2013).  The role of second-line chemotherapy in small cell lung cancer: a retrospective analysis.. Onco Targets Ther. 6, 1493-500.
Zarogoulidis, P., Hohenforst-Schmidt W., Huang H., Sapalidis K., Kosmidis C., Tryfon S., et al. (2020).  Vapor for lung volume reduction; pros and cons.. Expert Rev Respir Med. 14(12), 1189-1195.
Zarogoulidis, P., Petridis D., Ritzoulis C., Darwiche K., Spyratos D., Huang H., et al. (2013).  Establishing the optimal nebulization system for paclitaxel, docetaxel, cisplatin, carboplatin and gemcitabine: back to drawing the residual cup.. Int J Pharm. 453(2), 480-7.
Zarogoulidis, P., Kosmidis C., Fyntanidou V., Barmpas A., Koulouris C., Aidoni Z., et al. (2019).  Elastography during convex-probe (endobronchial ultrasound) for optimal biopsy sample and gene identification in non-small-cell lung cancer.. Biomark Med. 13(14), 1153-1156.
Zarogoulidis, P., Terzi E., Kouliatsis G., Androuli S., Kontakiotis T., Zaramboucas T., et al. (2011).  Orbital metastases as the first manifestation of lung adenocarcinoma.. Case Rep Ophthalmol. 2(1), 34-8.
Zarogoulidis, P., Trakada G., & Zarogoulidis K. (2013).  A chrono-target chemotherapy treatment model for lung cancer treatment.. Ther Deliv. 4(1), 5-8.
Zarogoulidis, P., Papadopoulos V., Maragouli E., Papatsibas G., Sardeli C., Man Y-G., et al. (2018).  Nivolumab as first-line treatment in non-small cell lung cancer patients-key factors: tumor mutation burden and PD-L1 ≥50.. Transl Lung Cancer Res. 7(Suppl 1), S28-S30.
Zarogoulidis, P., Petridis D., Ritzoulis C., Li Q., Huang H., Ning Y., et al. (2013).  Further experimentation of inhaled; LANTUS, ACTRAPID and HUMULIN with todays' production systems.. Int J Pharm. 458(1), 39-47.
Zarogoulidis, P., Kioumis I., Ritzoulis C., Petridis D., Darwiche K., Porpodis K., et al. (2013).  New insights in the production of aerosol antibiotics. Evaluation of the optimal aerosol production system for ampicillin-sulbactam, meropenem, ceftazidime, cefepime and piperacillin-tazobactam.. Int J Pharm. 455(1-2), 182-8.
Zarogoulidis, P., Katsikogianni F., Tsiouda T., Sakkas A., Katsikogiannis N., & Zarogoulidis K. (2014).  Interleukin-8 and interleukin-17 for cancer.. Cancer Invest. 32(5), 197-205.
Zarogoulidis, P., Kouliatsis G., Papanas N., Spyratos D., Constantinidis T. C., Kouroumichakis I., et al. (2011).  Long-term respiratory follow-up of H1N1 infection.. Virol J. 8, 319.
Zarogoulidis, P., Porpodis K., Kioumis I., Petridis D., Lampaki S., Spyratos D., et al. (2014).  Experimentation with inhaled bronchodilators and corticosteroids.. Int J Pharm. 461(1-2), 411-8.
Zarogoulidis, P., Darwiche K., Krauss L., Huang H., Zachariadis G. A., Katsavou A., et al. (2013).  Inhaled cisplatin deposition and distribution in lymph nodes in stage II lung cancer patients.. Future Oncol. 9(9), 1307-13.
Zarogoulidis, P., Christakidis V., Petridis D., Sapalidis K., Kosmidis C., Vagionas A., et al. (2020).  Connection between PD-L1 expression and standardized uptake value in NSCLC: an early prognostic treatment combination.. Expert Rev Respir Med.
Zarogoulidis, K., Zarogoulidis P., Darwiche K., Tsakiridis K., Machairiotis N., Kougioumtzi I., et al. (2013).  Malignant pleural effusion and algorithm management.. J Thorac Dis. 5 Suppl 4, S413-9.
Zarogoulidis, P., Kioumis I., Papanas N., Manika K., Kontakiotis T., Papagianis A., et al. (2012).  The effect of combination IFN-alpha-2a with usual antituberculosis chemotherapy in non-responding tuberculosis and diabetes mellitus: a case report and review of the literature.. J Chemother. 24(3), 173-7.
Zarogoulidis, P., Orfanidis M., Constadinidis T. C., Eleutheriadou E., Kontakiotis T., Kerenidi T., et al. (2011).  A 26-year-old male with mesothelioma due to asbestos exposure.. Case Rep Med. 2011, 951732.
Zarogoulidis, P., Kioumis I., Porpodis K., Spyratos D., Tsakiridis K., Huang H., et al. (2013).  Clinical experimentation with aerosol antibiotics: current and future methods of administration.. Drug Des Devel Ther. 7, 1115-34.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές